Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2022 | Recent advances in the management of STS

Patrick Schoffski • 9 Sep 2022
ESMO 2022
Sarcoma

Patrick Schöffski, MD, MPH, KU Leuven, Leuven, Belgium, discusses treatment strategies for soft tissue sarcomas (STS), highlighting heterogeneity of the disease as well as recent advances in the identification of molecular drivers of STS. Prof. Schöffski touches on the development of MDM2-targeting agents as a potential therapeutic avenue for this patient population. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France.

More from Patrick Schoffski

Phase I dose-escalation and expansion study evaluating BI 907828 in patients with solid tumours
2:02
Phase I dose-escalation and expansion study evaluating BI 907828 in patients with solid tumours
Patrick Schoffski • 9 Sep 2022
BI 907828: targeting MDM2 in solid tumors
0:51
BI 907828: targeting MDM2 in solid tumors
Patrick Schoffski • 9 Sep 2022
BOS172738 in RET-altered tumors
4:09
BOS172738 in RET-altered tumors
Patrick Schoffski • 21 May 2021

Related Videos

Using spatial RNA-protein profiling to identify ADC targets in LMS
1:20
Using spatial RNA-protein profiling to identify ADC targets in LMS
Carlos Torrado • 1 Jun 2026
Afami-cel T-cell therapy outcomes in advanced metastatic synovial sarcoma
1:52
Afami-cel T-cell therapy outcomes in advanced metastatic synovial sarcoma
Margaret von Mehren • 31 May 2026
ChonDRAgon: secondary efficacy data of ozekibart in conventional chondrosarcoma
1:46
ChonDRAgon: secondary efficacy data of ozekibart in conventional chondrosarcoma
Margaret von Mehren • 31 May 2026
APROMISS: catequentinib hydrochloride in alveolar soft part sarcoma
2:18
APROMISS: catequentinib hydrochloride in alveolar soft part sarcoma
Margaret von Mehren • 31 May 2026

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJOncology is intended for healthcare professionals